Physiological Sexual Dysfunction
Conditions
Interventions
This study will be a controlled and randomized clinical trial with two groups, conducted using a double-blind methodology. Patients diagnosed with myositis will be invited to participate in the study.
Sponsors
Faculdade de Medicina da Universidade de São Paulo
Faculdade de Medicina da Universidade de São Paulo
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Older than 18 years; women; diagnosis of systemic autoimmune myopathies; presenting sexual dysfunction
Exclusion criteria
Exclusion criteria: Pregnant; history of gynecological neoplasia; pelvic irradiation; gynecological tract infections; sexually transmitted diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to observe an improvement in sexual dysfunction, assessed from the Female Sexual Function Index (FSFI) questionnaire in the Portuguese version, set pre and post-intervention (meetings for sexual orientation), finally, we expect an improvement of 25% between assessments | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in quality of life (25%), according to the EuroQol-5D questionnaire (EQ-5D) evaluated pre and post-intervention | — |
Countries
Brazil
Contacts
Public ContactLorenza Silvério da Silva
Faculdade de Medicina da Universidade de São Paulo
Outcome results
None listed